UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blink patterns and lid-contact times in dry-eye and normal subjects

Clinical ophthalmology (Auckland, N.Z.), 2014-01, Vol.8 (default), p.869-874

2014

Volltextzugriff (PDF)

RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model

Scientific reports, 2018-07, Vol.8 (1), p.10500-14, Article 10500

2018

Volltextzugriff (PDF)

Blink: Characteristics, Controls, and Relation to Dry Eyes

Current eye research, 2018-01, Vol.43 (1), p.52-66

2018

Volltextzugriff (PDF)

Thymosin β4: a potential novel dry eye therapy

Annals of the New York Academy of Sciences, 2012-10, Vol.1270 (1), p.45-50

2012

Volltextzugriff (PDF)

Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye

Clinical ophthalmology (Auckland, N.Z.), 2013-01, Vol.7 (default), p.1275-1285

2013

Volltextzugriff (PDF)

Automated grading system for evaluation of ocular redness associated with dry eye

Clinical ophthalmology (Auckland, N.Z.), 2013-01, Vol.7 (default), p.1197-1204

2013

Volltextzugriff (PDF)

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

Clinical ophthalmology (Auckland, N.Z.), 2016, Vol.10 (Issue 1), p.887-895

2016

Volltextzugriff (PDF)

Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye

Investigative ophthalmology & visual science, 2015-04, Vol.56 (4), p.2340-2347

2015

Volltextzugriff (PDF)

Diurnal variation of visual function and the signs and symptoms of dry eye

Cornea, 2010-06, Vol.29 (6), p.607-612

2010

Volltextzugriff (PDF)

The Ocular Protection Index

Cornea, 2008-06, Vol.27 (5), p.509-513

2008

Volltextzugriff (PDF)

Optimizing Reading Tests for Dry Eye Disease

Cornea, 2015-08, Vol.34 (8), p.917-921

2015

Volltextzugriff (PDF)

Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects

Journal of ocular pharmacology and therapeutics, 2017-11, Vol.33 (9), p.686-692

2017

Volltextzugriff (PDF)

Diurnal Tracking of Blink and Relationship to Signs and Symptoms of Dry Eye

Cornea, 2016-08, Vol.35 (8), p.1104-1111

2016

Volltextzugriff (PDF)

Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial

Clinical ophthalmology (Auckland, N.Z.), 2011-01, Vol.5 (default), p.633-643

2011

Volltextzugriff (PDF)

Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review

Ophthalmology and therapy, 2017-12, Vol.6 (2), p.263-276

2017

Volltextzugriff (PDF)

Investigation of extended blinks and interblink intervals in subjects with and without dry eye

Clinical ophthalmology (Auckland, N.Z.), 2013-01, Vol.7 (default), p.337-342

2013

Volltextzugriff (PDF)

A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2019-06, Vol.126 (6), p.792-800

2019

Volltextzugriff (PDF)

An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis

Clinical therapeutics, 2007-04, Vol.29 (4), p.611-616

2007

Volltextzugriff (PDF)

Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model

Clinical ophthalmology (Auckland, N.Z.), 2015-01, Vol.9 (default), p.877-884

2015

Volltextzugriff (PDF)

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

Cornea, 2021-10, Vol.40 (10), p.1290-1297

2021

Volltextzugriff (PDF)

Dry eye in 2008

Current opinion in ophthalmology, 2009-07, Vol.20 (4), p.282-286

2009

Volltextzugriff (PDF)

Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: A randomized, double-masked crossover study

Clinical therapeutics, 2008-07, Vol.30 (7), p.1264-1271

2008

Volltextzugriff (PDF)

Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials

Clinical ophthalmology (Auckland, N.Z.), 2024-01, Vol.18, p.2193-2203

2024

Volltextzugriff (PDF)

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

The ocular surface, 2022-10, Vol.26, p.166-173

2022

Volltextzugriff (PDF)

TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China

International ophthalmology, 2022-08, Vol.42 (8), p.2459-2472

2022

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(52)
magazinearticle
(8)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Blink patterns and lid-contact times in dry-eye and normal subjects

RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model

Blink: Characteristics, Controls, and Relation to Dry Eyes

Thymosin β4: a potential novel dry eye therapy

Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye

Automated grading system for evaluation of ocular redness associated with dry eye

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye

Diurnal variation of visual function and the signs and symptoms of dry eye

The Ocular Protection Index

Optimizing Reading Tests for Dry Eye Disease

Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects

Diurnal Tracking of Blink and Relationship to Signs and Symptoms of Dry Eye

Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial

Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review

Investigation of extended blinks and interblink intervals in subjects with and without dry eye

A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease

An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis

Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

Dry eye in 2008

Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: A randomized, double-masked crossover study

Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China

Suchergebnisse filtern